The Scientist

» NFL

Most Recent

A Congressional investigation indicates that the National Football League may have sought to steer millions of dollars in National Institutes of Health funding away from one of its critics.

0 Comments

image: Opinion: The Burden of Proof

Opinion: The Burden of Proof

By | January 30, 2014

Universities that profit from football programs need to honestly assess their responsibilities when it comes to head injury research.

2 Comments

image: NFL Gear Yields Little for Cancer

NFL Gear Yields Little for Cancer

By | October 16, 2013

Only a small proportion of money made from breast cancer-themed football merchandise actually supports efforts to combat the disease.  

0 Comments

image: NFL Settles Concussion Case

NFL Settles Concussion Case

By | August 29, 2013

The National Football League will pay a total of $765 million to help cover the medical expenses of more than 4,500 former players and to fund research on head injuries.

2 Comments

image: Junior Seau Had Brain Trauma

Junior Seau Had Brain Trauma

By | January 10, 2013

An NIH study finds that the former NFL linebacker who committed suicide last May had signs of degenerative brain disease.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham